In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-3 of 3 for your search:
Drug:  HLA-A*2402-restricted VEGFR1/2 multipeptide vaccine
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 20 to 85
Sponsor: Other
Protocol IDs: SUMS-22-15, 22-15, NCT01949688

2.

Phase: Phase I
Type: Treatment
Status: Active
Age: 20 to 85
Sponsor: Other
Protocol IDs: MBCCTA-001-STT, NCT01259505

3.

Phase: Phase I
Type: Treatment
Status: Active
Age: 20 to 80
Sponsor: Other
Protocol IDs: 560, NCT01266707
New Search